FDA product code OTX: Foot Wrap For Treating Restless Leg Syndrome Symptoms

OTX is the FDA product code for foot wrap for treating restless leg syndrome symptoms. It is a Class I device, regulated under 21 CFR 890.5760 and reviewed by the Neurology panel. Devices under OTX reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

Applying compression to the muscles of the foot for the purpose of affecting nerve impulses sent to the central nervous system.

Classification

FieldValue
Device nameFoot Wrap For Treating Restless Leg Syndrome Symptoms
Device classClass I
Regulation21 CFR 890.5760
Review panelNE — Neurology
Medical specialtyPhysical Medicine
Premarket route510(k) exempt

Recalls for OTX devices

FDA recall records list no recalls for product code OTX.

Frequently asked questions

What is FDA product code OTX?

OTX is the FDA product code for foot wrap for treating restless leg syndrome symptoms. It is a Class I device, regulated under 21 CFR 890.5760 and reviewed by the Neurology panel.

What device class is OTX?

Class I, regulation 21 CFR 890.5760. Typical premarket route: 510(k) exempt.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times